Genetic determinants of cellular addiction to DNA polymerase theta by Feng, W. et al.
ARTICLE
Genetic determinants of cellular addiction to DNA
polymerase theta
Wanjuan Feng1, Dennis A. Simpson1, Juan Carvajal-Garcia 1, Brandon A. Price1, Rashmi J. Kumar1,
Lisle E. Mose1, Richard D. Wood 2, Naim Rashid1,3, Jeremy E. Purvis4, Joel S. Parker 1,4, Dale A. Ramsden1,5 &
Gaorav P. Gupta 1,5,6
Polymerase theta (Pol θ, gene name Polq) is a widely conserved DNA polymerase that
mediates a microhomology-mediated, error-prone, double strand break (DSB) repair path-
way, referred to as Theta Mediated End Joining (TMEJ). Cells with homologous recombi-
nation deficiency are reliant on TMEJ for DSB repair. It is unknown whether deficiencies in
other components of the DNA damage response (DDR) also result in Pol θ addiction. Here
we use a CRISPR genetic screen to uncover 140 Polq synthetic lethal (PolqSL) genes, the
majority of which were previously unknown. Functional analyses indicate that Pol θ/TMEJ
addiction is associated with increased levels of replication-associated DSBs, regardless of the
initial source of damage. We further demonstrate that approximately 30% of TCGA breast
cancers have genetic alterations in PolqSL genes and exhibit genomic scars of Pol θ/TMEJ
hyperactivity, thereby substantially expanding the subset of human cancers for which Pol θ
inhibition represents a promising therapeutic strategy.
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DNA double strand breaks (DSBs) arise spontaneouslyduring DNA replication or upon exposure to exogenousclastogens and threaten both genome integrity and
cellular viability1–3. Efficient and accurate DSB repair is thus
vital for cancer prevention and organismal survival. DSB repair
pathways are broadly classified into two categories: homology-
directed repair (HDR) and non-homologous end joining
(NHEJ). HDR requires 5′ to 3′ end resection, Rad51 loading,
strand invasion, and DNA synthesis using an intact homo-
logous template4. In contrast, classical NHEJ (c-NHEJ)
does not require a homologous template and is dependent
on the Ku complex, DNA-PK, and XRCC4/Ligase 45. An
alternative end joining (alt-EJ) pathway has also been descri-
bed, but unlike c-NHEJ, alt-EJ acts on the same 5′ to 3′ resected
DSBs that are intermediates in HR. Alt-EJ employs a synthesis-
dependent mechanism that is directed by short tracts of
flanking microhomology (MH)1,6, giving rise to a characteristic
pattern of MH-flanked deletions and/or templated insertions.
Several genes have been implicated in alt-EJ, including 5′ to 3′
resection factors (e.g., Mre11, Rad50, Nbn, CtiP, and Exo1),
PARP1, and LIG3. However, the gene that is most specifically
linked to Alt-EJ is the A-family DNA Polymerase θ (Pol θ, gene
name Polq)1,7. Alt-EJ signatures at chromosomal breaks are
substantially reduced in Polq−/− cells from diverse metazoan
and plant organisms8–10. Thus, Pol θ has emerged as the pre-
dominant mediator of alt-EJ, and this alternative DSB repair
pathway has been designated Theta Mediated End Joining
(TMEJ)9,11.
TMEJ is intrinsically an error-prone pathway, yet its evolu-
tionary conservation in metazoans and plants suggests that it
likely has a physiological role in promoting genome integrity1.
Indeed, Polq−/− cells demonstrate elevated levels of sponta-
neous DNA damage12. A prior study suggested that TMEJ
competes with HDR for DSB repair13, but this model does not
explain how TMEJ may promote genome stability. In C. ele-
gans, TMEJ has an important role in the repair of replication-
associated DSBs, particularly at G-quadruplex (G4)
structures14,15. In that study, Pol θ deficiency resulted in large-
scale deletions at chromosomal G4 sites. However, the phy-
siological role of TMEJ in promoting genome integrity in
mammals remains unclear.
In normal cells, TMEJ accounts for a small minority of DSB
repair10. Consistent with a limited role in global DSB repair,
Polq deficiency has a relatively minor impact on organismal
development in flies16, worms17, and mice12. However, recent
studies have demonstrated that Polq nevertheless becomes
essential in cells with deficiency in canonical DSB repair
pathway genes (Brca1, Brca2, and Ku70), indicating synthetic
lethal genetic interactions that are consistent with an essential
role for Polθ/TMEJ as a backup to repair by either HR or
NHEJ10,13,18. This observation has resulted in enthusiasm for
Pol θ as a therapeutic target in breast and ovarian cancers with
BRCA1/2 deficiency19. However, it remains unknown whether
Polq is also synthetic lethal with other genes in the HR and
NHEJ pathways, and more broadly, with other genetic media-
tors of the DNA damage response (DDR) pathway. Here, we
report findings from a synthetic lethal CRISPR screen to
identify DDR gene mutations that induce cellular addiction to
Pol θ. We uncover a broad landscape of synthetic lethality with
Polq, and provide evidence that this reflects a critical role for
Pol θ in protecting cells from accumulation of non-productive
HR intermediates at sites of DNA replication-associated DSBs.
Finally, we find that human breast cancers with mutations in
Polq synthetic lethal (PolqSL) genes identified in our CRISPR
screen may be addicted to Pol θ, based on increased expression
of TMEJ-associated genomic scars.
Results
CRISPR synthetic lethal screens. To gain broader insight into
the contexts where Pol θ-mediated genome maintenance is
essential for cellular viability, we performed a CRISPR loss of
function screen in WT, Polq−/−, and PolqhPOLQ (Polq−/−
reconstituted with human POLQ) MEF cell lines, which were
described previously and functionally validated10,12,20. Polq−/−
MEFs have a normal cell cycle profile10, yet exhibit elevated levels
of spontaneous chromosomal aberrations that are reversed after
complementation with human POLQ (Supplementary Fig. 1). The
goal of the CRISPR screen was to identify gene mutations that are
tolerated inWT and PolqhPOLQ MEFs yet lethal in Polq−/− MEFs,
thereby indicative of a synthetic lethal genetic interaction. A
custom synthesized “DDR-CRISPR” lentiviral library was used
for the screen, which targets 309 murine DDR genes with
10 small guide RNAs (sgRNAs) per gene and also includes 834
non-targeting sgRNA controls (Supplementary Data 1). For each
biological replicate, 2 × 106 MEFs were transduced with the DDR-
CRISPR lentiviral library at low multiplicity of infection (<1), and
passaged for 8 population doublings prior to genomic DNA
isolation (Fig. 1a). High-throughput sequencing (average 250×
read depth) was used to quantify the abundance of each sgRNA
sequence relative to all mapped reads, similar to previously
described methods21 (Fig. 1a). A “Gene Abundance Change
Score” was calculated as described in the methods. Thresholds for
statistical significance were established by using the set of control
sgRNAs as an internal control for abundance changes that are
due to off-target effects (see “Methods”).
Plotting the Gene Abundance Change Scores, we observed a
striking depletion of many DDR gene-targeting sgRNAs in Polq−/−
relative to WT MEFs (Fig. 1b). In contrast, control sgRNAs were
not depleted in Polq−/− cells and, in fact, were enriched relative to
their abundance inWT cells due to the depletion of a large number
of DDR gene-targeting sgRNAs. Moreover, the vast majority of
sgRNA abundance changes in Polq−/− MEFs could be definitively
attributed to Pol θ deficiency, as they were not observed when
Polq−/− cells were reconstituted with WT human POLQ
(PolqhPOLQ) (Fig. 1b). To mitigate any clone-specific genetic
interactions we directly compared Gene Abundance Change Scores
in Polq−/− MEFs relative to PolqhPOLQ MEFs, and identified
142 significant genetic interactions using two complementary
statistical tests (Fig. 1c). All but two of these genes (140 total) had
corresponding sgRNAs that were depleted in Polq−/− MEFs
relative to reconstituted PolqhPOLQ MEFs, and thus classified as
Polq synthetic lethal (PolqSL) genes.
Due to the large proportion of Polq synthetic lethal gene
interactions identified in our screen (45% of 309 genes
evaluated), we performed two additional control experiments.
First, we conducted the same DDR-CRISPR screen in an
immortalized MEF line that is deficient in another DNA repair
polymerase, Pol µ (Polm), that participates in NHEJ repair22.
We did not identify any statistically significant synthetic lethal
gene interactions with Polm deficiency (Supplementary Fig. 2a,
b and Supplementary Data 3), indicating the broad landscape of
DDR gene synthetic lethality is not observed for all DNA
repair-associated polymerases. To address whether Polq−/−
cells are prone to synthetic sickness with Cas9-mediated gene
editing events, we utilized a separate CRISPR library targeting
genes that encode membrane proteins. Only 19 out of 951 genes
(2%) targeted in this library exhibited synthetic lethality with
Polq−/−, which is below the 3% false discovery rate threshold
used during statistical analyses (Supplementary Fig. 2c, d and
Supplementary Data 3). Thus, the large number of PolqSL
genes identified in our screen is due to a broad landscape of
DDR gene mutations that render cells dependent on Polq for
viability.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12234-1
2 NATURE COMMUNICATIONS |         (2019) 10:4286 | https://doi.org/10.1038/s41467-019-12234-1 | www.nature.com/naturecommunications
We validated 15 of the candidate PolqSL genes using standard
colony forming assays after transduction with gene-targeting or
control sgRNAs (Fig. 1d). For 14 out of 15 genes, we observed
significantly reduced viability in Polq−/− MEFs relative to WT
MEFs (i.e., 93% hit validation rate). We also tested sgRNAs against
Brca1 in WT and Polq−/− MEFs, due to previously published
reports of a synthetic lethal interaction13,18, although Brca1 did not
emerge as a significant genetic interaction in our CRISPR screen.
We observed a modest yet statistically significant reduction in cell
viability when sgBrca1 was introduced in Polq−/− cells relative to
WT cells. The relatively small magnitude of viability difference
between Polq−/− and WT MEFs transduced with sgBrca1 may
explain why it was a false negative result in our screen.
Previous work identified two members of the HR pathway
(Brca1 and Brca2)13,18, and 1 member of the NHEJ pathway
(Ku70)10, as synthetic lethal with Polq deficiency. Our work
considerably expands the list of DSB repair genes that are
synthetic sick or lethal with Polq, such that it now includes 13
additional HR mediators, as well as 4 additional genes specific to
NHEJ (Fig. 1e, Supplementary Data 2). We also observed highly
significant synthetic sickness between Polq deficiency and all four
components of the 53BP1 anti-resection pathway included in our
screen (53bp1, Paxip1, Mad2l2, and Rif1). Surprisingly, many of
the remaining PolqSL genes have no direct role in canonical DSB
repair. These include genes involved in base/nucleotide excision
repair, translesion synthesis, mismatch repair, DNA metabolism,
DDR signaling, chromatin structure, and the Fanconi Anemia
repair pathway (Fig. 1e). We postulated that a common feature of
these gene mutations may be an increase in endogenously
generated replication-associated DSBs. To directly test whether
Pol θ is essential for repair of collapsed replication forks, we
quantified chromosomal aberrations after Aphidicolin treatment.
Polq−/− MEFs accumulated significantly more metaphase
aberrations and had reduced viability after aphidicolin treatment
relative to WT or PolqhPOLQ MEFs (Supplementary Fig. 3a-c).
Loss of Neil3 has previously been shown to increase replication-
associated DSBs23. We identified Neil3 as a PolqSL gene, and
observed that CRISPR-mediated knockout of Neil3 increased
nuclear 53BP1 foci more significantly in Polq−/− MEFs relative to
WT MEFs, which is consistent with an accumulation of
unrepaired replication-associated DSBs. Collectively, these find-
ings argue an essential role for Polq is not limited to cells deficient
in BRCA1/2, or even cells deficient in DSB repair—we show Pol θ
is an important compensatory repair mechanism in the back-
ground of deficiency in many genes implicated in DDR.
Synthetic lethality of Polq/53bp1 DKO cells despite HR and
NHEJ proficiency. Synthetic lethality between Polq and 53bp1
has previously been reported10, and had been presumed to be due
to deficiency in NHEJ. To evaluate this possibility, we measured
NHEJ, HR, and TMEJ repair at a CRISPR/Cas9 induced break at
the murine Rosa26 locus using digital PCR (dPCR) assays































































































































































































Fig. 1 Identification of Polq synthetic lethal (PolqSL) genes by CRISPR screening. a Schematic of the CRISPR genetic screen to identify PolqSL genes. b Violin
plot of Gene Abundance Change Scores (Log2) for DDR gene-targeting sgRNAs (red) and non-targeting control sgRNAs (blue) in Polq−/− and PolqhPOLQ
MEFs, relative to WT MEFs. c Volcano plot of Gene Abundance Change Scores (Polq−/− versus PolqhPOLQ) and -Log10 p-value of the Kolmogorov-Smirnov
test for DDR gene-targeting sgRNAs relative to non-targeting control sgRNAs. Thresholds for statistical significance are indicated by dashed lines (see
“Methods” for details). Genes with statistically significant (Blue dots) and non-significant (Gray dots) Gene Abundance Changes Scores are indicated.
Genes with red/purple triangles are further validated in Fig. 1d. d Relative cell survival measured by colony forming efficiency of WT or Polq−/− cells
transduced with a lentivirus containing Cas9 and control sgRNA (sgCtrl) or DDR gene-targeting sgRNAs. Data shown are the mean ± SEM (n= 3 biological
replicates). Significance determined using an unpaired, two-tailed t-test (*p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001). e Functional classification of
PolqSL genes identified in our CRISPR screen depicted as a Euler diagram
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Fig. 2 Synthetic lethality of Polq/53bp1 double knockout cells despite HR and NHEJ proficiency. a Schema for marker-free quantification of DSB repair
pathway choice at a CRISPR-induced chromosomal break using dPCR. b Quantification of HR, NHEJ, and TMEJ repair at the Rosa26 locus, relative toWT+
sgCtrl. Data shown are the mean ± SEM (n= 3 biological replicates). Significance determined using an unpaired, two-tailed t-test (*p < 0.05; **p < 0.01;
****p < 0.0001). c Diagram of growth competition assay to assess kinetics of synthetic lethality between Polq and 53bp1. DD-Cas9 is protected from
degradation upon exposure to a synthetic ligand (Shield1). Depletion of mVenus-positive cells over time after Shield1 exposure is indicative of sgRNA
lethality. d Normalized percentage of mVenus-positive cells over time after Shield1 treatment, measured by flow cytometry. The mean fraction of mVenus-
positive cells ± SEM (n= 3) is shown for the various genotypes, normalized to day 0 (no shield). Polq−/−+ sg53bp1-1 or -2 ****, p < 0.0001 using two-
tailed nonparametric Spearman correlation in GraphPad Prisim v7.04. e–g Time lapse microscopy of PCNA-mCherry to assess cell cycle phase transitions
in individual Polq−/− cells 48 h after Shield1 treatment. Cell lines used in this experiment are described in (c) after mVenus sorting. e Image descriptions for
the three mitotic outcomes. Mitotic catastrophe is a terminal event with cells undergoing nuclear degradation, and abnormal mitosis refers to cytokinesis
failure or chromosomal mis-segregation events resulting in abnormal nuclear structure in subsequent daughter cells. f Distribution of S phase lengths in
Polq−/− MEFs transduced with sgCtrl, sg53bp1-1, and sg53bp1-2. **p < 0.01 using a two-tailed t-test. g Analysis of mitotic outcome of individual cells with
the indicated genotypes. Abnormal mitosis refers to cytokinetic failure or mis-segregation events resulting in abnormal nuclear structure in subsequent
daughter cells. Mitotic catastrophe refers to abnormal mitoses resulting in cell death or disappearance. Significance determined using a Chi-square test
(**p < 0.01 and ****p < 0.0001)
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sequencing analyses at this locus10 (Fig. 2a). 53bp1 deficiency
resulted in a nonsignificant reduction in NHEJ and increased
frequencies of both HR and TMEJ repair (Fig. 2b), consistent
with previously described roles for 53bp1 in DSB repair pathway
choice24. Based on these observations, NHEJ deficiency cannot
explain synthetic lethality between 53bp1 and Polq. However, it
was also surprising that HR could not compensate for TMEJ
deficiency in 53bp1/Polq DKO cells, given that they both act on
resected DSBs. We therefore investigated the synthetic lethal
phenotype in greater detail.
To assess kinetics of synthetic lethality between 53bp1 and Polq,
we utilized an inducible Cas9 expression system (DD-Cas925), and
monitored the relative growth rate of transduced cells by flow
cytometry over time (Fig. 2c). Interestingly, although 53BP1
expression was already diminished by 48 h after Shield1 treatment
(Supplementary Fig. 4), the growth disadvantage of Polq−/−+
sg53bp1 (i.e., Polq/53bp1 double knockout, DKO) cells persisted
over at least 14 days (Fig. 2d). Time lapse microscopy using
PCNA-mCherry as a fluorescent cell cycle reporter26 revealed a
statistically significant prolongation of S phase duration with one
out of two 53bp1-targeting sgRNAs in Polq−/− cells (Fig. 2f),
although G1 and G2/M duration did not differ significantly for any
of the genotypes (Supplementary Fig. 5). More strikingly, there was
a significantly higher rate of aberrant mitoses (improper
chromosomal segregation or abnormal cytokinesis) and mitotic
catastrophe when either of the 53bp1 targeting sgRNAs was
expressed in Polq−/− cells (Fig. 2e, g).
Polq/53bp1 DKO cells accumulate aberrant HR intermediates
in S phase. Because mitotic aberrations can arise from unresolved
DNA damage in the preceding S phase27–29, we performed co-
immunofluorescence for Rad51 and γH2AX to assess levels of HR
intermediates and DNA damage-associated chromatin, respec-
tively. Notably, we observed large Rad51 aggregates selectively in
Polq/53bp1 DKO cells, which frequently were also positive for
γH2AX (Fig. 3a, b). The Rad51 foci observed in Polq/53bp1 DKO
cells were substantially larger than spontaneous Rad51 foci that
occur in a normal S phase inWT cells (Supplementary Fig. 6a–b).
In addition, we analyzed EdU incorporation to distinguish non-S
phase cells from cells in early, middle, or late S phase (Fig. 3c).
The most significant increase in abnormal Rad51 aggregates was
observed in middle and late S phase cells (Fig. 3d). We hypo-
thesized that these Rad51 foci arose from spontaneous replication
fork collapse. Indeed, aphidicolin treatment increased the per-
centage of nuclei with large Rad51 foci (Fig. 3e). Furthermore,
Rad51 foci that formed in Polq/53bp1 DKO cells persisted even
after 12 h, a timepoint when a significant fraction of Rad51 foci
had resolved in WT, WT+ sg53bp1, and Polq−/− cells (Fig. 3e
and Supplementary Fig. 6c). Collectively, these observations
indicate that synthetic lethality between 53bp1 and Polq defi-
ciency is due to unsuccessful HR-mediated repair of a subset of
replication-associated DSBs.
Polq is required for Mitomycin C (MMC) induced DNA
damage repair. We next evaluated potential roles for Pol θ after
exposure to agents known to cause stalled replication forks,
including MMC, which introduces interstrand crosslinks (ICL),
and pyridostatin (PDS), which stabilizes G quadruplex (G4)
DNA. Prior findings in Drosophila8,12,30 have implicated Polq in
ICL repair. In contrast, MEFs expressing a hypomorphic Polq
allele, Polqchaos1, were not hypersensitive to MMC12. We find that
Polq−/− MEFs are hypersensitive to MMC, which can be restored
by reconstitution with human POLQ (Supplementary Fig. 7). The
discrepancy between these findings may be due to residual
activity of the Polqchaos1 allele in mediating ICL repair. Polq−/−
MEFs exposed to a low dose of MMC (20 ng/mL) had a sig-
nificantly higher frequency of mitotic crossovers in a sister
chromatid exchange (SCE) assay and unrepaired chromosomal
aberrations than was observed in wild type cells. Increases in both
classes of aberrations were reversed upon exogenous expression
of human POLQ (Fig. 4a–c). These observations indicate that
TMEJ is a major pathway for ICL repair in mammals that pre-
vents accumulation of mitotic crossovers. Notably, Polq−/− cells
treated with MMC also accumulated large Rad51 foci (Fig. 4d–f),
similar in character to those observed in Polq and 53bp1 DKO
cells.
Polq is required for pyridostatin induced DNA damage repair.
Pol θ has been implicated in repair of replication-dependent
DNA damage at G4 DNA in C. elegans14,15. Our CRISPR screen
identified a synthetic sickness genetic interaction between Polq
and Fancj, which was validated by performing a colony forming
assay (Fig. 1d). Fancj is a conserved helicase that unfolds G4
DNA31 and mutations in its C. elegans ortholog, dog-1, result in
high levels of TMEJ signature repair at G4 sites in the genome32.
We found that Polq−/− MEFs are hypersensitive to the
G4 stabilizer pyridostatin (PDS)33 relative to WT cells (Fig. 5a).
Similarly, WT MEFs transduced with sgRNA targeting the Polq
polymerase domain induced sensitivity to PDS relative to a
control sgRNA (Fig. 5b). Polq−/− cells treated with PDS accu-
mulate a significantly greater number of Rad51 and 53BP1 foci
(Fig. 5c–e). Interestingly, Rad51 foci in Polq−/− cells were larger
and more frequently adjacent to 53BP1 foci than in WT cells
(Supplementary Fig. 8). Altogether, these observations demon-
strate an essential role for Pol θ in protection against accumu-
lation of non-productive HR intermediates at sites of replication-
associated DNA damage.
Elevated TMEJ repair signatures in cells with PolqSL gene
mutations. We next investigated whether there was more frequent
utilization of TMEJ for DSB repair in cells deficient in genes
represented in the PolqSL list. We first induced chromosomal
breaks in a wild type MEF line, as well as stable variants of this line
deficient in 53bp1 (53bp1−/−) or Brca2 (Brca2Mut/−) (Supple-
mentary Fig. 9), and characterized repair of these breaks by high
throughput sequencing (Fig. 6a). TMEJ events were defined as
deletions >5 bp with >2 bp flanking microhomology (MHD), which
is a signature pattern of repair product that has previously been
shown to be Pol θ-dependent in this cell line10. Both of the PolqSL
list gene mutants (Brca2 and 53bp1) showed increased use of the
TMEJ signature (Fig. 6b, c), although 53bp1−/− had longer MHD
compared to Brca2Mut/-, likely due to increased DSB resection in
53bp1 deficient cells. Similar results were observed using a dPCR
assay specific for a Pol θ-dependent MHD in cells that were
CRISPR-targeted for two additional HR genes in the PolqSL list,
Palb2 and Rad51 (Fig. 6d, e). Frequent synthetic lethality with Polq
deficiency thus tightly correlates with the importance of TMEJ as a
commonly used compensatory, or backup mechanism for repair of
replication-associated DSBs.
Elevated TMEJ repair signatures in human breast cancers with
PolqSL gene alterations. The association between PolqSL gene
mutations and increased utilization of TMEJ repair in MEFs led
us to hypothesize that human cancers with PolqSL gene muta-
tions may also contain higher levels of TMEJ-associated genomic
scars. Towards this end, we identified 275 out of 926 (29.7%)
breast cancers in the TCGA cohort34 as likely deficient in one or
more of the 140 PolqSL genes identified in our CRISPR screen
(Supplementary Data 4–5), due to a truncating mutation or a
deep copy number deletion. Notably, this is a much larger
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fraction of cancers than previously considered as having addic-
tion to Pol θ—only 21 of these 275 cases were BRCAmutated. We
observed significantly higher levels of POLQ mRNA (Fig. 6f) in
breast cancers with PolqSL gene alteration. We also investigated
correlation with COSMIC mutation signature 3, which is upre-
gulated in cancers with BRCA1/2 deficiency and also in BRCA
non-mutant cancers with suspected homologous recombination
deficiency (HRD)35,36. We observed highly significant enrich-
ment of COSMIC signature 3 in breast cancers with PolqSL gene
alterations (Fig. 6g), relative to breast cancers without PolqSL
gene alteration. These observations are consistent with excessive
employment of Pol θ in PolqSL deficient cancers. We further
explored this possibility by implementing a validated algorithm
for indel detection37 to quantify the signature readout of TMEJ
repair—microhomology-flanked deletions (MHD), defined as
deletion size of 5 bp or greater and 2 bp or more of flanking
microhomology. Breast cancers with PolqSL gene alterations were
significantly more likely to have a detectable TMEJ signature
MHD identified from whole exome sequencing (WES) analyses
(Fig. 6h). As expected, whole genome sequencing (WGS) iden-
tified a 20-fold higher rate of TMEJ signature MHD than WES in
a subset of 94 TCGA breast cancers for which both WES and
WGS were performed (Fig. 6i, Supplementary Data 6). Forty one
out of 94 (43.6%) breast cancers with WGS data available in
TCGA had PolqSL gene alterations, and this subset of cancers had
significantly higher levels of TMEJ signature MHD than cancers
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Fig. 3 Polq/53bp1 double knockout cells accumulate non-productive HR intermediates in S phase. a Representative immunofluorescence (IF) staining of
Rad51 (red) and γH2AX (green) foci formation in cells with the indicated genotypes, 48 h after Shield1 treatment. (n= 3 biologically independent
experiments). b Quantification of large Rad51 foci per nucleus and percentage of nucleus with Rad51 foci. Data shown are mean ± SEM, and consistent
across three independent biological replicates. ***p < 0.001; ****p < 0.0001 using a Mann–Whitney test. c Representative co-IF images for Rad51 (red),
γH2AX (green), and EdU (yellow,10min EdU pulse) in Polq−/−+ sg53BP1-2 MEFs to distinguish cell cycle stages as indicated. d Quantification of large
Rad51 foci per nucleus stratified by cell cycle stage. *p < 0.05; **p < 0.01; ****p < 0.0001 by a Mann–Whitney test. e Cells were treated with 10 µM
Aphidicolin for 4 h followed by release for 0, 6, and 12 h, fixed cells and stained cells with Rad51. Quantification of the percentage of nuclei with Rad51 foci
was performed. Data shown are mean ± SEM, and consistent across two independent biological replicates. *p < 0.05; **p < 0.01 using a Mann–Whitney test
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without PolqSL gene alterations (Fig. 6j). Thus, mimicking our
findings in genetically engineered MEFs, we find that human
breast cancers with deficiency in PolqSL genes have multiple
indices of a hyperactive TMEJ repair pathway.
Discussion
We have defined a surprisingly diverse landscape of DDR gene
mutations that renders cells addicted to TMEJ for survival. The
functional diversity of PolqSL genes suggests that Pol θ becomes
essential upon increased levels of endogenous, unrepaired DNA
damage, regardless of the precise nature of that damage. The lack of
specificity for a specific type of DNA damage argues against a
translesion synthesis function for Pol θ, and is consistent with Pol θ-
mediated repair of replication-associated DSBs via TMEJ. Indeed, we
found Pol θ is essential for repair of DSBs arising from aphidicolin-



























































































































































































Fig. 4 Polq is required for Mitomycin C induced DNA damage repair. a Metaphase aberrations and sister chromatid exchanges are shown in WT, Polq−/−
and PolqhPOLQ cells 12 h after treatment with 20 ng/mL Mitomycin C (MMC). Scale bar= 10 µm. b, c Quantification of (a), 35 metaphase spreads for each
condition was scored, and shown are mean ± SEM. Significance determined using an unpaired, two-tailed t-test (*p < 0.05; ****p < 0.0001). d IF analysis of
WT, Polq−/−, and PolqhPOLQ cells six hours after treatment with 20 ng/mL MMC, stained with DAPI (blue) and antibodies specific for Rad51 (red) and
53BP1 (green) (n= 3 biologically independent experiments). (e, f) are quantification of (d). Statistical significance was assessed by unpaired, two-tailed
Mann–Whitney tests (***p < 0.001; ****p < 0.0001)
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Fig. 5 Polq is required for Pyridostatin induced DNA damage repair. a Colony forming efficiency after treatment with Pyridostatin (PDS, 1, 2, 5 µM) in WT
and Polq−/− MEFs. b Colony forming efficiency after treatment with Pyridostatin (PDS, 1, 2, 5 µM) in WT MEFs transduced with Cas9 and either sgCtrl or
sgPolq (targeting the polymerase domain). a, b Data shown are the mean ± SEM (n= 3). Statistical significance was assessed by two-tailed t-tests. *p <
0.05, **p < 0.01 and ***p < 0.001. c IF images for DAPI (blue), Rad51 (red) and 53BP1 (green) inWT and Polq−/− MEFs six hours after treatment with 5 µM
PDS (n= 3 biologically independent experiments). d, e are quantification of large Rad51 and 53BP1 foci, as observed in (c). Shown are mean ± SEM, and
representative of three independent experimental replicates. Statistical significance was assessed by Mann–Whitney tests. **p < 0.01, ***p < 0.001, and
****p < 0.0001
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12234-1
8 NATURE COMMUNICATIONS |         (2019) 10:4286 | https://doi.org/10.1038/s41467-019-12234-1 | www.nature.com/naturecommunications
Whilst prior studies suggested that TMEJ primarily functions
as a backup pathway to HR and NHEJ, our study identifies
numerous examples of TMEJ essentiality when canonical DSB
repair pathways are unperturbed. Analysis of synthetic lethality in
53bp1/Polq DKO cells reveals an accumulation of unrepaired HR
intermediates in S phase that is further exacerbated by
aphidicolin-induced replication fork collapse. We also find TMEJ
essentiality upon G quadruplex stabilization and after exposure to
interstrand crosslinking agents, both of which promote replica-
tion fork stalling and/or collapse. These observations suggest that
TMEJ is required for repair of a subset of replication-associated
DSBs that is not amenable to repair by HR (Fig. 7). An example of
such a break could be one where the template contains a
replication-blocking lesion. Recent evidence supports a model
wherein unresolved replication-blocking lesions can be inherited
as tracts of single-stranded gaps surrounding the lesion15,38,39.
Replication of these lesions in daughter cells would give rise to
two-ended DSBs that are not amenable to HR due to persistence
of the replication-blocking lesion in the template DNA strand
(Fig. 7, left panel). TMEJ may be a preferred repair mechanism at
these sites due to its ability to re-join resected breaks without
requiring a homologous template (Fig. 7, right panel). Thus, we
postulate that DDR gene mutations that induce a higher pre-
valence of unresolved replication-blocking lesions may induce
TMEJ essentiality. Alternative activities of Pol θ may also be
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Fig. 6 Elevated TMEJ repair signatures in cells and cancers with PolqSL gene mutations. aWT, 53bp1−/−, and Brca2Mut/− MEFs were transfected with Cas9
ribonucleoprotein (Cas9-RNP) targeting the Rosa26 locus. Forty-eight hours later the targeted region was amplified and analyzed by high throughput
sequencing (Illumina MiSeq). b Percentage of repair products classified as NHEJ (≤5 bp del, or 1–3 bp insertion), TMEJ (>5 bp deletion and >2 bp MH), and
“Other” (>5 bp deletion and 0–2 bp MH), for the indicated MEF genotypes. c The relative frequency (normalized toWT) of end joining products with >2 bp
MH and deletion size within the indicated ranges. 53bp1−/− MEFs are associated with larger-sized TMEJ signature deletions. b, c Mean values ± SEM (n=
6) are shown. Significance determined using an unpaired, two-tailed t-test (*p < 0.05; **p < 0.01; ***p < 0.001). d, e DNA repair products are detected by
digital PCR using WT MEFs transduced with the indicated PolqSL gene-targeting sgRNA. HR is detected after co-transfection of a homology donor. Relative
rates (normalized to WT+ sgCtrl) of (d) homologous recombination (HR) and (e) TMEJ (95 bp deletion with 5 bp MH) are indicated as mean values ±
SEM (n= 3). Significance determined using an unpaired, two-tailed t-test (***p < 0.001; ****p < 0.0001). f–j Analysis of breast cancers in TCGA. PolqSL
mutant breast cancers are identified using cBioPortal as having a truncating mutation or deep copy number deletion. POLQ mRNA expression (f) and
COSMIC Signature 3 (g) are elevated in cancers with PolqSL gene alterations. h–j Whole exome sequencing (WES) and whole genome sequencing (WGS)
analyses in TCGA breast cancers to detect MH-flanked deletions (MHD). h Breast cancers with PolqSL gene alterations are more likely to have a
detectable MHD by WES than breast cancers without alteration in PolqSL genes. The error bar is a bootstrapped 95% confidence interval. WGS data is
available for 94 TCGA breast cancers. i High correlation between MHD detected by WGS or WES. j Significantly higher MHD count, detected by WGS,
among breast cancers with PolqSL gene alterations, relative to the non-altered breast cancers. f–g, i–j Statistical significance was assessed by two-tailed
Mann–Whitney tests. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001
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studies have shown that Pol θ can promote microhomology-
mediated integration of plasmid DNA, implying an ability to
invade donor templates that lack overt DSBs40,41. Future studies
will be necessary to unravel the mechanism by which Pol θ
resolves stalled or collapsed replication forks, and its relationship
to HR-mediated repair.
Our findings also demonstrate that a hallmark feature of cells
and cancers with gene mutations that induce Pol θ addiction is an
increased prevalence of TMEJ pattern genomic scars. The striking
similarity and overlap between genomic scar signatures pre-
viously ascribed to HR deficiency (HRD) or “BRCA-ness”42,43
and TMEJ repair raises the distinct possibility that hyperactive
TMEJ is the etiologic driver of this genomic scar pattern in
human cancer. While we have shown that HRD induces hyper-
active TMEJ, our study also demonstrates that non-HR gene
alterations (such as 53BP1) are also sufficient to induce TMEJ
hyperactivity and addiction. An important clinical implication of
these findings is that only a subset of cancers identified by HRD
or BRCA-ness genomic scar signatures may be functionally HR
deficient. This may explain the incomplete correlation between
HRD signatures and functional HR assays44, and the recent
finding that HRD signatures are unable to accurately predict
platinum chemotherapy sensitivity in metastatic breast cancer
patients45. We propose that genomic classifiers that incorporate
COSMIC signature 3, and especially MHD burden, may be more
precisely described as “hyper-TMEJ” signatures, rather than sig-
natures specific for HRD.
Our study suggests that cancers with “hyper-TMEJ” signatures
may be dependent on Pol θ for their survival. Recent pan-cancer
genomic analyses46,47 suggest that hyper-TMEJ signatures and
PolqSL gene deficiency may account for as many as 20% of all
human cancers, thus greatly expanding the number of cancers for
which Pol θ represents an attractive therapeutic target. Refining
the optimal “hyper-TMEJ” genomic scar signature that predicts
Pol θ addiction in human cancers will be a clinically relevant area
of future investigation.
Methods
Cell culture. WT (Polq+/+), Polq−/−, Polm−/−, and Polm+/+ cells were SV-40
large T antigen immortalized MEFs12,20,22, while PolqhPOLQ MEFs were generated
by complemented Polq−/− MEFs by human POLQ cDNA expression20. 293T cells
were purchased from ATCC (CRL11268). All cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM), with 10% Bovine Calf Serum (Hyclone BCS)
and 2 mM L-glutamine (ThermoFisher). PolqhPOLQ cells were maintained in the
same media supplemented with 2 μg/ml puromycin. All cells were maintained at
37 °C in an atmosphere of 5% CO2. Cells in culture were routinely monitored for
mycoplasma contamination using the Plasmo Test™ (Invivogen).
Oligo synthesis and pooled library cloning. DNA oligonucleotide sgGuide
library was synthesized by LC Sciences (Supplementary Data 1). A subset of this
library was then amplified by PCR using AmpliTaq Gold® 360 DNA Polymerase
(ThermoFisher) with forward primer ArrayF and reverse primer ArrayR (Sup-
plementary Data 7) followed by purification with MinElute PCR Purification Kit
(Qiagen) to produce a double strand product suitable for Gibson cloning48. The
CRISPR library cassette was cloned into lentiCRISPR v2 (a gift from Feng Zhang,
Addgene plasmid # 52961) followed by transformation into Endura™ Electro-
Competent Cells (Lucigen) according to the manufacturer’s protocol using BTX
Gemini system (ThermoFisher). To ensure no loss of representation, six parallel
transformations were performed using the same Gibson reaction and plated into
twelve, 10 cm petri dishes (VWR) containing LB agar (ThermoFisher) with 100 µg/
ml carbenicillin (ThermoFisher). Colonies were scraped off plates and combined
for DNA extraction (Qiagen).
Lentivirus generation. Lentiviruses were generated by 293T cells in 150 mm dish
with transfection of 3 µg pMD2.G (a gift from Didier Trono, Addgene # 12259),
4.5 µg psPAX2 (a gift from Didier Trono, Addgene # 12260) and 6 µg custom
DDR-CRISPR pooled lentiviral library, transfection was performed using Poly-
ethylenimine (Linear, MW 25,000, Polysciences, Inc)49,50. Supernatant from the
packaging reaction was collected at 48 h and 72 h. This was pooled and then filtered
through 0.45 μm filter. The virus was then concentrated by pelleting at 113,000 × g
in a SW28 ultracentrifuge rotor for two hours at 4 °C. The pellet was allowed to
dissolve overnight in desired volume of PBS at 4 °C and then aliquoted and frozen
at −80 °C.
CRISPR library screening. Our custom DDR-CRISPR pooled lentiviral plasmid
library containing 3908 sgRNAs targeting 309 murine DNA damage response
(DDR) genes with an average of 10 sgRNAs per gene, as well as 834 non-targeting
sgRNA controls was used to infect cells at a MOI ~0.8. Twenty-four hours after
addition of virus, the media was removed and replaced with fresh media. Forty-
eight hours after adding the virus the cells were split. One million cells from each
infection was seeded into a 15 cm dish in media containing 2 μg/ml puromycin.
Cells were passaged once every two to three days, 1 × 106 cells were reseeded into a
15 cm plate each time. After 8 population doublings, cells were harvested and
genomic DNA isolated using QIAamp DNA Blood Kit (Qiagen). To amplify
lentiCRISPRv2 sgRNAs, PCR was performed in two steps: For the first PCR, the
amount of input genomic DNA (gDNA) for each sample was calculated to achieve
120 X coverage over the DDR-CRISPR library, which resulted in 5 μg DNA per
sample (assuming 6.6 μg of gDNA for 106 cells). For each sample 5 separate 100 μl
PCR reactions with 1 μg genomic DNA in each reaction using Herculase II Fusion
DNA Polymerase (Agilent) were carried out using DDR_CRISPR_Ion_1st_FWD
and DDR_CRISPR_Ion_1st_REV and then combined. A second PCR was per-
formed to attach Ion adaptors and to barcode samples. The second PCR was done
in two 50 μl reactions using around 80 ng product from the first PCR. Primer
sequences for the first and second PCR are attached in Supplementary Data 7.
Amplification was carried out with 30 cycles for the first PCR and 10 cycles for the
second PCR. Twenty-four to twenty-eight libraries were then pooled and
sequenced on an Ion S5 (ThermoFisher) using the 530v1 chip.
The “membrane CRISPR library” was obtained from Addgene (ID:
1000000124), and targets 951 genes that encode membrane associated proteins51.
Pooled CRISPR library lentivirus was transduced into WT and Polq−/− cells
expressing Shield1-inducible DD-Cas9-mVenus. We sorted at least 2 × 106 cells
expressing both DD-Cas9 (mVenus) and membrane CRISPR library (mCherry)
before adding Shield1 treatment. 24 h after Shield1, cells were passaged once every
two to three days, by reseeding 1 × 106 cells into a 15 cm plate each time. We
performed the same genomic DNA extraction and library prep and Ion sequencing
as our DDR CRISPR library, except the first round primers for membrane CRISPR
library amplification were: MMB_CRISPR_Ion_1st_FWD and
MMB_CRISPR_Ion_1st_REV (Supplementary Data 7).
CRISPR library analysis. The number and significance of guides present for each
library in the multiplexed FASTQ file is determined using our custom algorithm
(Völundr). Völundr identifies and counts the sgRNA sequence in the FASTQ reads
allowing for a single mismatch in the sequence. It then writes a count file for each
library in the pool and a summary file describing the FASTQ file and the libraries.
The count files are used by the Völundr target analysis module as the input data for
determining which genes are significantly different than the biological control
TMEJNon-productive
HR
Rad51/HR Pol θ/TMEJ 
Fig. 7 Model for TMEJ in suppressing non-productive HR at replication-
associated DNA damage. Orange triangle indicates a replication-
obstructing lesion, such as ICL, G4, or base damage, with an associated
region of under-replicated DNA. Converging replication forks will generate
a two-ended DSB that can undergo end resection to expose 3′ overhangs.
Rad51 loading and attempted HR may result in unsuccessful repair due to
persistence of the replication blocking lesion in the homologous template
DNA. Alternatively, TMEJ is able to perform microhomology-mediated end
joining of the exposed 3′ overhangs, without requiring a homologous
template
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sample. To accomplish this the counts in each file are first normalized to the total
counts for its library (Supplementary Note 1 see Eq. 1). The normalized data from
the replicate samples are then combined on a per guide basis by determining the
geometric mean for each guide across replicates (Supplementary Note 1 see Eq. 2).
At this step the sgRNA TDNorm value and sgRNA Abundance Change Scores are
determined as shown in Supplementary Note 1 see Eq. 3. Any guides with no
counts in the Plasmid sample are masked from all analysis steps at this point. The
“Gene Abundance Change Scores” are determined as in Supplementary Note 1 see
Eq. 4. For each sgRNA targeting a gene of interest, “ABC”, the experimental sample
sgGuide TDNorm value is first subtracted from the corresponding biological sample
control sgGuide TDNorm value. The log2 transformed, geometric mean of this set is
the “Gene Abundance Change Scores”. These scores are also computed in the next
section on the control guides to empirically estimate the distribution of the Gene
Abundance Change Scores in the absence of real biological change using a
resampling-based scheme.
The Völundr pipeline takes two different approaches to determine if a targeted
gene is significantly different than the biological control. The first is to estimate an
empirical null distribution for the Gene Abundance Change Scores by randomly
sampling ten non-targeting guides (sgControl) sgRNA TDNorm values, from the
834 sgControl guides a total of 100,000 times (Python NumPy, random choice).
For each random set of control guides sampled, we repeat the procedure of the
prior paragraph to calculate an empirical Gene Abundance Change Score. The
99.99 percentile and 0.01 percentile values are used as the boundaries for the null
set. The second method uses the Kolmogorov-Smirnov test to determine if the
sgRNA Abundance Change Scores for the genes were drawn from the same
population sgRNA Abundance Change Scores for the sgControls. The p-values of
the Kolmogorov-Smirnov test (Python Scipy Stats, ks_2samp) are corrected for
multiple tests using a false discovery of 3% with the two-stage linear step-up
procedure of Benjamini, Krieger and Yekutieli found in GraphPad Prisim v7.04.
The first test evaluates the observed score distribution across the 10 guides for a
gene relative to the empirical null distribution across randomly sampled sets of 10
control guides. The second score evaluates the overall gene sgRNA Abundance
Change Score relative to the overall sgControl sgRNA Abundance Change Score.
For stringency, we require genes to pass both tests to be reported as significant.
Establishment of mammalian expression constructs and stable cell lines. DNA
corresponding to sgRNAs was cloned into LentiCRISPRv2 (a gift from Feng Zhang,
Addgene # 52961), or DD-Cas9 (a gift from Raffaella Sordella, Addgene plasmid #
90085), or pGL3-U6-sgRNA-PGK-puromycin (A gift of Xingxu Huang, Addgene #
51133), using the same protocol described above. Cells were incubated with fresh
lentivirus for 24 h and then were recovered for another 24 h. Infected cells are
selected by 2 μg/μl puromycin or mVenus by flow cytometry.
For 53BP1 and Brca2 mutant cell lines, we used the Alt-R CRISPR-Cas9 system
(IDT). We performed transfection using the Neon transfection kit (Invitrogen)
according to manufacturer’s protocol. Alt-R HiFi Cas9 nuclease, crRNA and
tracrRNA were purchased from IDT and were used at the manufacturer’s
recommended concentration; crRNA is designed using MIT CRISPR (http://crispr.
mit.edu). Forty-eight hours after transfection, cells were seeded for single clone
outgrowth, PCR screening and Sanger sequencing to confirm gene targeting, and
subsequent functional tests.
Synthetic lethal and colony formation assay. Two individual sgRNAs were
chosen to target each gene. Forty-eight hours after infection, infected cells were
selected by puromycin and counted for colony formation efficiency. Cells were
incubated for 7–10 days at 37 °C to allow colony formation. Colonies were stained
by Coomassie blue. sgRNA sequences are attached in Supplementary Data 7.
Competitive growth assay. DD-Cas9-sgRNA was transduced into the indicated
cell lines by lentivirus infection. Forty-eight hours later, mVenus positive cells were
quantified by flow cytometry. Normally, more than 50% cells are mVenus positive
cells. Cells were treated with 200 nM Shield1 (Takara) and were collected for flow
cytometry at the indicated time points.
Time-Lapse microscopy. Cells stably expressing Proliferating Cell Nuclear Anti-
gen (PCNA)-mCherry were transduced with DD-Cas9-sgRNA. PCNA-mCherry
fusion reporter is a gift from Dr. Jeremy Purvis and Hui Chao Xiao. Cells were
plated on Cell-Tak (Corning) coated glass-bottom 12-well plates (Cellvis) with
Phenol-free DMEM (Invitrogen) supplemented with 10% FBS, and L-glutamine
with or without Shield1. Forty-eight hours post plating, cells were image captured
every 20 min for 72 h in the mCherry and mVenus fluorescence channels. Fluor-
escence images were obtained using a Nikon Ti Eclipse inverted microscope with a
40x objective and Nikon Perfect Focus (PFS) system to maintain focus during
acquisition period. Cells were maintained at constant temperature (37 °C) and
atmosphere (5% CO2). Image analysis was performed on ImageJ – Fiji.
DNA repair assay. Cell lines used in the assay are indicated in the figure. 2 × 106
cells were transfected with 5 μg pGL3-U6-sgRNA-PGK-puromycin (A gift of
Xingxu Huang, Addgene # 51133), 5 μg Flag-Cas9 (A gift of Xingxu Huang,
Addgene # 44758), with or without 10 μg HR long donor10 and 1 μg pEGFP-N2
(Takara) by Neon transfection kit (Invitrogen) using a 1350 V, 30 ms pulse in a
100 μL chamber. Forty-eight hours post transfection, a portion of the cells were
analyzed by flow cytometry to quantify the transfection efficiency, and the
remaining cells were harvested for genomic DNA extraction (Qiagen). Digital PCR
(QX-200, Bio-Rad) was performed to quantify the frequency of gene conversion
events using the primers and Taqman probes listed in Supplementary Data 7. The
repair signal was normalized to 5000 copies of genomic DNA, measured using a
Chromosome 6 control dPCR assay, using primers/probes sequences listed in
Supplementary Data 7. Analysis of dPCR data was performed using QuantaSoft
(Bio-Rad).
Immunofluorescence. Cells were permeabilized by CSK buffer (10 mM Hepes,
300 mM Sucrose, 100 mM NaCl, 3 mM MgCl2, and 0.5% Triton X-100, pH= 7.4)
for 2 min followed by fixation for 15 min in 3% paraformaldehyde. Cells were
subsequently processed for immunostaining experiments using the indicated
antibodies. Nuclei were visualized by staining with DAPI. The primary antibodies
used were: Rad51 (1:500, Novus Biologicals, NB100-148), γH2AX (1:500, Trevigen,
4418-APC-100), and 53BP1 (1:500 for immunofluorescence, 1:5000 for western
blot, Bethyl, A300-272A). The secondary antibodies were: Rhodamine Goat Anti-
Mouse IgG (H+ L) (1:500, Jackson ImmunoResearch, 115-025-146) and FITC
Goat Anti Rabbit IgG (H+ L) (1:500, Jackson ImmunoResearch, 111-095-144). For
S phase stain, we incubated cells with 10 μM EdU for 10 min, EdU was detected
according to the EdU-Click 647 kit protocol (baseclick). Images were acquired
using an Olympus BX61 fluorescence microscope or Zeiss 880 with Airyscan
processing for the super-resolution images.
Metaphase and sister chromatin exchange assay. Metaphases were prepared by
a previously published method52 with the noted changes. Cells were treated with
100 ng/ml of Colcemid (KaryoMAX® 15210-040 from Gibco) for 1 h prior to
harvest and swelling in 75 mM potassium chloride for 20 min at 37 °C. Once the
metaphases were dropped onto slides, the slides were stored at room temperature
for at least two days prior to staining with Giemsa (KaryoMAX® 10092-013 from
Gibco) for 2–3 min. After staining, the slides are rinsed with distilled water and
allowed to air dry completely before mounting the coverslips with DPX Mountant
(Millipore Sigma). Spreads were imaged under a 100× objective using an Olympus
BX61 Light Microscope with QImaging RETIGA 4000R camera.
The SCE assay was performed as previously described53. Briefly, 24 h after cells
were plated, 10 μM bromodeoxyuridine (BrdU) (Millipore-Sigma) was added to the
plates for 24 h. MMC (20 ng/ml, Millipore-Sigma) was added for the final 12 h in
BrdU. For the final hour 100 ng/ml of Colcemid (KaryoMAX® 15210-040 from
Gibco) was added to the media. The cells were harvested by trypsinization and
processed for metaphase spreads as described above. After 2–3 days the metaphases
were stained for 30 min by placing the slides in a Coplin jar containing 10 µg/ml
Hoechst 33342 (Thermo Fisher) in PBS. The slides were then removed from the
Hoechst solution and placed in a tray of 2 × SSC (20 × SSC Stock: 3 M sodium
chloride with 300 mM sodium citrate) on a 45 °C heat block. While in the warm
SSC the metaphases where exposed to UVB radiation from a Danmar UVB
compact fluorescent bulb (peak emission 365 nM) at a distance of 5 cm for 20 min.
After exposure to UVB place the slides in a Coplin jar of 2 × SSC for ≥10 min to let
the Hoechst and degraded DNA wash away. The slides were then stained with
Giemsa (KaryoMAX® 10092-013 from Gibco) for 5 min. The slides were cover
slipped and imaged as described above for metaphases.
High throughput sequencing. Two hundred nanograms of genomic DNA were
amplified using a two-step PCR that added unique library bar-codes, heterogeneity
spacers and Illumina MiSeq adapters (as in54). Two-step PCR primers are attached
in Supplementary Data 7. Samples were sequenced using a 2 × 300 MiSeq kit55.
Quantification and classification of the sequences was done in R and excel.
Analysis of MHD in human breast cancers. TCGAWES reads were aligned using
bwa-mem (Li, 2013, arXiv:1303.3997 [q-bio.GN]) and realigned using ABRA2
(https://github.com/mozack/abra2)37. Read duplicates were marked by bio-
bambam2 (https://github.com/gt1/biobambam256,). Variants were called with
Strelka57, UNCeqR58 and Cadabra37 (https://cadabra.science). Variant calls were
annotated with the Variant Effect Predictor (VEP)59. For TCGA cases where WGS
data were available, reads were trimmed using SeqPurge60, aligned using bwa-mem
and realigned using ABRA2. Read duplicates were marked by biobambam2 and
indels were called using Cadabra. Variant calls were annotated with VEP. TCGA
mRNA reads were aligned to human reference genome hg38 using STAR61 and
quantified with Salmon62 which was run against STAR’s transcriptome alignments.
Quantification values were upper quantile normalized.
MHD were defined as deletions ≥ 5 bp in length with ≥ 2 bp of flanking
microhomology. To determine flanking microhomology, the 3′ end of the deletion
was matched to the sequence directly upstream of the deletion junction. Deletions
located in regions enriched in short repeats were ignored. MHD in TCGA breast
cancer samples were summed per sample with a sample being classified as having
MHD if at least one occurrence of MHD was observed.
PolqSL mutant TCGA samples were identified as having at least one deep copy
number deletion or truncating mutation in a PolqSL gene using cBioPortal. POLQ
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mRNA expression, COSMIC mutation signature 3 scores63, and proportion of
samples with MHD were compared between PolqSL mutant and non-mutant
groups using a two-tailed Mann–Whitney test.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequencing data is available at [https://www.ncbi.nlm.nih.gov/sra/PRJNA556352].
Unanalyzed raw data is available at [https://figshare.com/projects/Genetic_Determinants_
of_Cellular_Addiction_to_DNA_Polymerase_Theta/67331]. All data is available from the
corresponding author upon request. The source data underlying Figs. 1d, 2b, d, f, g, 3b, d, e,
4b, c, e, f, 5a, b, d, e, 6b–e and Supplementary Figs. 1, 3, 5, 6, 7a and 8 are provided as a
source data file.
Code availability
Code for Völundr has been made publicly available at [https://github.com/pkMyt1/
Volundr]. Other software for statistical analysis is publicly available and referenced
as noted.
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